Table 3. 1H and 13C signal enhancements (ε) and 13C2 singlet lifetimes of deuterated analogues.
Complex | ε 1H hydride/fold | ε 13C2 imine/fold | 13C2 singlet lifetime/s |
1A-d14 | 110 | 510 | 7.9 ± 0.9 |
1A-d38 | 300 | 560 | 19.9 ± 1.0 |
1A-15N-d24 | 480 | 750 | 17.5 ± 3.9 |
2A-d32 | 740 | 340 | N/A |
2A/3A | N/A | 2A, 220 | N/A |
3A, 190 | |||
2A-d32/3A-d33 | 2A-d32, 720 | 2A-d32, 330 | N/A |
3A-d33, 380 | 3A-d33, 260 | ||
Pyridine, 0 | |||
2A/3A-15N | 2A, 230 | 2A, 230 | N/A |
3A-15N, 390 | 3A-15N, 260 | ||
Pyridine, 190 | |||
1A-15N-d24/3A-15N2-d24 | 1A-15N-d24, 1620 | 2A N/A a | N/A |
3A-15N2-d24, 590 | 3A-15N, N/A a | ||
Pyridine, 870 |
aSpectral overlap prevents signal enhancements being calculated for each complex. Note pyridine enhancements include bound and free signals.